Goebell PJ, et al. - In patients being treated for metastatic renal cell carcinoma (mRCC) in Germany, authors evaluated the prognostic impact of body mass index (BMI). As per data, high BMI was significantly and independently associated with longer OS in a prospective German cohort of mRCC routine patients starting first-line systemic treatment. They noted an independent association of Memorial Sloan Kettering Cancer Center risk factors with shorter OS.